Pretargeting for imaging and therapy in oncological nuclear medicine
Pretargeting for imaging and therapy in oncological nuclear medicine
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Oncological pretargeting has been implemented and tested in several different ways in preclinical models and clinical trials over more than 30 years. Despite highly promising results, pretargeting has not achieved market approval even though it could be considered the ultimate theranostic, combining PET imaging with short-lived positr...
Alternative Titles
Full title
Pretargeting for imaging and therapy in oncological nuclear medicine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d8551b493b254c6699eda614f4cadf5d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d8551b493b254c6699eda614f4cadf5d
Other Identifiers
ISSN
2365-421X
E-ISSN
2365-421X
DOI
10.1186/s41181-017-0026-8
